GMPS
Summary: In the de novo synthesis of purine nucleotides, IMP is the branch point metabolite at which point the pathway diverges to the synthesis of either guanine or adenine nucleotides. In the guanine nucleotide pathway, there are 2 enzymes involved in converting IMP to GMP, namely IMP dehydrogenase (IMPD1), which catalyzes the oxidation of IMP to XMP, and GMP synthetase, which catalyzes the amination of XMP to GMP. [provided by RefSeq, Jul 2008].
Loading, please wait...
Name | OMIM ID | Ensembl ID | HGNC ID | PHARMGKB ID | Map Location |
---|---|---|---|---|---|
OMIM IDMIM:600358 Ensembl IDEnsembl:ENSG00000163655 HGNC IDHGNC:HGNC:4378 PHARMGKB IDPA28763 Map Location3q25.31 |
GO terms in GMPS
Loading, please wait...
Term Type | Evidence Type | GO Term ID | GO Des. |
---|---|---|---|
MF | IBA | GO:0003824 | catalytic activity |
MF | EXP | GO:0003921 | GMP synthase activity |
MF | IBA | GO:0003921 | GMP synthase activity |
MF | IBA | GO:0003922 | GMP synthase (glutamine-hydrolyzing) activity |
MF | IEA | GO:0005524 | ATP binding |
MF | IEA | GO:0016462 | pyrophosphatase activity |
Gene expression in normal tissue: GMPS
Gene-model tissue-cancer distribution: Bubble Plot
Gene-drug pathway distribution
Pathways in GMPS
Loading, please wait...
Database | Pathway ID | Pathway Des. |
---|---|---|
pharmgkb | PA2040 | Thiopurine Pathway, Pharmacokinetics/Pharmacodynamics |
kegg | hsa00230 | Purine metabolism - Homo sapiens (human) |
kegg | hsa00983 | Drug metabolism - other enzymes - Homo sapiens (human) |
humancyc | PWY-7221 | guanosine ribonucleotides de novo biosynthesis |
humancyc | PWY-7228 | guanosine nucleotides de novo biosynthesis |
humancyc | PWY-841 | purine nucleotides de novo biosynthesis |
Gene-Drug: Aster Plot
Gene in drug-gene network: Network Plot

Gene-drug targets distribution
Gene Structure: PDB
Models in GMPS
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |